A citation-based method for searching scientific literature

Ramesh B Kasetti, Prabhavathi Maddineni, Bindu Kodati, Bhavani Nagarajan, Sam Yacoub. Int J Mol Sci 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Extracellular matrix turnover and outflow resistance.
Kate E Keller, Mini Aga, John M Bradley, Mary J Kelley, Ted S Acott. Exp Eye Res 2009
169
100

LIM kinases: cofilin and beyond.
Chloé Prunier, Renaud Prudent, Reuben Kapur, Karin Sadoul, Laurence Lafanechère. Oncotarget 2017
53
100

Rho/Rho-associated kinase pathway in glaucoma (Review).
Jing Wang, Xiaohong Liu, Yisheng Zhong. Int J Oncol 2013
41
100

Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells.
Georges Kalouche, Fanny Beguier, Michael Bakria, Stéphane Melik-Parsadaniantz, Caroline Leriche, Thomas Debeir, William Rostène, Christophe Baudouin, Xavier Vigé. Invest Ophthalmol Vis Sci 2016
23
100

Trabecular meshwork stiffness in glaucoma.
Ke Wang, A Thomas Read, Todd Sulchek, C Ross Ethier. Exp Eye Res 2017
66
100

Effect of benzalkonium chloride on trabecular meshwork cells in a new in vitro 3D trabecular meshwork model for glaucoma.
Meryem Bouchemi, Christophe Roubeix, Karima Kessal, Luisa Riancho, Anne-Laure Raveu, Hayet Soualmia, Christophe Baudouin, Françoise Brignole-Baudouin. Toxicol In Vitro 2017
22
100

One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, Yasuaki Kuwayama, Haruki Abe, Atsuki Fukushima, Hideki Suganami, Makoto Araie. Acta Ophthalmol 2016
71
100

Effects of prostaglandin analogues on aqueous humor outflow pathways.
Nelson S Winkler, Michael P Fautsch. J Ocul Pharmacol Ther 2014
61
100

Structural changes of the trabecular meshwork in different kinds of glaucoma.
Ozan-Yüksel Tektas, Elke Lütjen-Drecoll. Exp Eye Res 2009
237
100

High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells.
Vesa Hongisto, Sandra Jernström, Vidal Fey, John-Patrick Mpindi, Kristine Kleivi Sahlberg, Olli Kallioniemi, Merja Perälä. PLoS One 2013
101
100

Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.
Mutsuki Amano, Masanori Nakayama, Kozo Kaibuchi. Cytoskeleton (Hoboken) 2010
602
100


The formation of cortical actin arrays in human trabecular meshwork cells in response to cytoskeletal disruption.
Kaitlin C Murphy, Joshua T Morgan, Joshua A Wood, Adeline Sadeli, Christopher J Murphy, Paul Russell. Exp Cell Res 2014
9
100


Matrigel: from discovery and ECM mimicry to assays and models for cancer research.
Gabriel Benton, Irina Arnaoutova, Jay George, Hynda K Kleinman, Jennifer Koblinski. Adv Drug Deliv Rev 2014
208
100

Phase 2 randomized clinical study of a Rho kinase inhibitor, K-115, in primary open-angle glaucoma and ocular hypertension.
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, Yasuaki Kuwayama, Haruki Abe, Makoto Araie. Am J Ophthalmol 2013
125
100

TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor.
Karen Y Torrejon, Ellen L Papke, Justin R Halman, Magnus Bergkvist, John Danias, Susan T Sharfstein, Yubing Xie. Sci Rep 2016
26
100

Diverse effects of pan-ROCK and ROCK2 inhibitors on 2 D and 3D cultured human trabecular meshwork (HTM) cells treated with TGFβ2.
Megumi Watanabe, Yosuke Ida, Hiroshi Ohguro, Chiaki Ota, Fumihito Hikage. Sci Rep 2021
5
100

Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells.
Padmanabhan P Pattabiraman, Ponugoti Vasantha Rao. Am J Physiol Cell Physiol 2010
124
100

Consensus recommendations for trabecular meshwork cell isolation, characterization and culture.
Kate E Keller, Sanjoy K Bhattacharya, Theresa Borrás, Thomas M Brunner, Sunee Chansangpetch, Abbott F Clark, W Michael Dismuke, Yiqin Du, Michael H Elliott, C Ross Ethier,[...]. Exp Eye Res 2018
129
100

Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension.
Richard A Lewis, Brian Levy, Nancy Ramirez, Casey C Kopczynski, Dale W Usner, Gary D Novack. Br J Ophthalmol 2016
59
100

Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis.
Guorong Li, Chanyoung Lee, A Thomas Read, Ke Wang, Jungmin Ha, Megan Kuhn, Iris Navarro, Jenny Cui, Katherine Young, Rahul Gorijavolu,[...]. Elife 2021
10
100

Effects of TGF-beta2 in perfused human eyes.
Johannes Gottanka, Darren Chan, Michael Eichhorn, Elke Lütjen-Drecoll, C Ross Ethier. Invest Ophthalmol Vis Sci 2004
195
100


Phase 1 clinical trials of a selective Rho kinase inhibitor, K-115.
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, Yasuaki Kuwayama, Haruki Abe, Makoto Araie. JAMA Ophthalmol 2013
81
100

Matrigel: a complex protein mixture required for optimal growth of cell culture.
Chris S Hughes, Lynne M Postovit, Gilles A Lajoie. Proteomics 2010
725
100

Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Janet B Serle, L Jay Katz, Eugene McLaurin, Theresa Heah, Nancy Ramirez-Davis, Dale W Usner, Gary D Novack, Casey C Kopczynski. Am J Ophthalmol 2018
109
100


Prostaglandins increase trabecular meshwork outflow facility in cultured human anterior segments.
Cindy K Bahler, Kyle G Howell, Cheryl R Hann, Michael P Fautsch, Douglas H Johnson. Am J Ophthalmol 2008
77
100

Rho kinase (ROCK) inhibitors.
James K Liao, Minoru Seto, Kensuke Noma. J Cardiovasc Pharmacol 2007
287
100

Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, Yasuaki Kuwayama, Haruki Abe, Hideki Suganami, Makoto Araie. JAMA Ophthalmol 2015
78
100

An emerging treatment option for glaucoma: Rho kinase inhibitors.
Sean K Wang, Robert T Chang. Clin Ophthalmol 2014
78
100

Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2.
R C Tripathi, J Li, W F Chan, B J Tripathi. Exp Eye Res 1994
422
100


Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.
T B Connor, A B Roberts, M B Sporn, D Danielpour, L L Dart, R G Michels, S de Bustros, C Enger, H Kato, M Lansing. J Clin Invest 1989
444
100

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
Anders Heijl, M Cristina Leske, Bo Bengtsson, Leslie Hyman, Boel Bengtsson, Mohamed Hussein. Arch Ophthalmol 2002
100

Targeting Transforming Growth Factor-β Signaling in Primary Open-Angle Glaucoma.
Jenny Wang, Alon Harris, Mark A Prendes, Loor Alshawa, Josh C Gross, Scott M Wentz, Ambika B Rao, Nathaniel J Kim, Alexander Synder, Brent Siesky. J Glaucoma 2017
21
100

Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.
Ponugoti Vasantha Rao, Padmanabhan P Pattabiraman, Casey Kopczynski. Exp Eye Res 2017
76
100

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Michael A Kass, Dale K Heuer, Eve J Higginbotham, Chris A Johnson, John L Keltner, J Philip Miller, Richard K Parrish, M Roy Wilson, Mae O Gordon. Arch Ophthalmol 2002
100


Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study.
Hidenobu Tanihara, Toshihiro Inoue, Tetsuya Yamamoto, Yasuaki Kuwayama, Haruki Abe, Hideki Suganami, Makoto Araie. Acta Ophthalmol 2015
72
100

Live cell imaging of actin dynamics in dexamethasone-treated porcine trabecular meshwork cells.
Tomokazu Fujimoto, Toshihiro Inoue, Miyuki Inoue-Mochita, Hidenobu Tanihara. Exp Eye Res 2016
12
100

CHI3L1 nuclear localization in monocyte derived dendritic cells.
Michelino Di Rosa, Daniele Tibullo, Salvatore Saccone, Gisella Distefano, Maria Sofia Basile, Francesco Di Raimondo, Lucia Malaguarnera. Immunobiology 2016
23
100


The many faces of the trabecular meshwork cell.
W Daniel Stamer, Abbot F Clark. Exp Eye Res 2017
118
100

Double-masked, randomized, dose-response study of AR-13324 versus latanoprost in patients with elevated intraocular pressure.
Jason Bacharach, Harvey B Dubiner, Brian Levy, Casey C Kopczynski, Gary D Novack. Ophthalmology 2015
83
100

Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
P V Rao, P F Deng, J Kumar, D L Epstein. Invest Ophthalmol Vis Sci 2001
324
100

Status of Rho kinase inhibitors in glaucoma therapeutics-an overview.
Bhawesh Chandra Saha, Rashmi Kumari, Rakhi Kushumesh, Anita Ambasta, Bibhuti Prasanna Sinha. Int Ophthalmol 2022
2
100

In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells.
Pascale Hamard, Catherine Blondin, Caroline Debbasch, Jean-Michel Warnet, Christophe Baudouin, Françoise Brignole. Graefes Arch Clin Exp Ophthalmol 2003
60
100

Cellular senescence in the glaucomatous outflow pathway.
Paloma B Liton, Pratap Challa, Sandra Stinnett, Coralia Luna, David L Epstein, Pedro Gonzalez. Exp Gerontol 2005
116
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.